Hematologic Risk
- Use under the supervision by experienced physician with cancer chemotherapy
- Hospitalization recommended for first course of therapy due to the possibility of severe toxic reactions.
Monitoring data
- Careful monitoring of WBC and platelet count is recommended.
Package inserts
Additional information
Updated: January 2018